Effect of Oxaliplatin+Palbociclib Combination Treatment in an In Vivo Model for CDK4/6 Inhibitor-Resistant CCA and Patient-Derived Organoid Models. The gene discussed is CDK4; the disease is cholangiocarcinoma.